baber/WOPTO huggingface dataset:
Patent FI-925400-A0 (FI)
Inventor: AKAGIRI KENZO
IPC: H03M7/30
Filed: 1992-11-27
Abstract: An apparatus for highly efficiently encoding digital signals by converting input digital signals into signals on a frequency axis in a blocked form, and encoding the input digital signals with a suitable number of assignment bits for each of said blocks to transmit them, wherein the input digital signals are subjected to the orthogonal conversion and are divided by a critical band, encoded with a suitable number of assignment bits based on an allowable noise level, and are subjected to the floating processing. When the floating processing is to be carried out by a plurality of small blocks of a band narrower than the critical band, information of word length of a small block is transmitted out of the small blocks in the critical bands, in order to reduce the bit number for the word length and to compress the bits. Moreover, when the floating processing is to be carried out by small blocks of bands narrower than the critical bands, allowable noise level and information of word length of a small block are transmitted for each of the critical bands instead of transmitting the floating coefficient for each of the critical bands, in order to decrease the number of transmission bits and to highly compress the bits. When the floating processing is to be carried out by small blocks of bands narrower than the critical bands, furthermore, information of a word length corresponding to the number of assignment bits is transmitted, and information related to allowable noise level whose designated range is deviated toward the lower side from the signal level range within the critical band by a predetermined amount of level, is obtained through a quantization table and is transmitted instead of transmitting the floating coefficient, in order to more highly compress the bits. <IMAGE>
Patent FI-925696-A0 (FI)
Inventor: DIMAIO JOHN
IPC: A61P7/02
Filed: 1992-12-15
Abstract: A thrombin inhibitor comprising a first bulky hydrophobic portion interacting with the catalytic site of thrombin responsible for proteolysis and a second portion at least maintaining the hydrophobic and acidic character of amino acids 55 to 60 of native hirudin at the C-terminal non-catalytic region of N-acetyl-hirudin45-65. Between the first and second portions is a divalent linker moiety having a chain length of at least 10 carbon atomes. Preferably, the bulky hydrophobic portion comprises at least one amino acid of D-configuration. The compounds are useful in the treatment of thrombotic disorders.
Patent FI-925739-A0 (FI)
Inventor: HIRSCHMANN KLEMENS
IPC: C03B37/10
Filed: 1992-12-17
Abstract: 2.1. The objective is to provide a process and an apparatus for the continuous production of mineral wool mats, by means of which a stable flow pattern is created in the chute, thus facilitating a clearly defined, homogeneous layer of deposited mineral wool. 2.2. According to the invention, at least one backflow region (24, 25) is generated in the chute (9) outside the fiber flow (23), which backflow region (24, 25) is sufficient for such a large-volume backflow with such a low mean velocity that appreciable upward fiber transport is avoided. In this connection, a portion (32) of the process air entrained with the fiber flow is deflected upward in the backflow, and another portion (34) of the process air is extracted. 2.3. Production of mineral wool. <IMAGE>
Patent FI-931144-A0 (FI)
Inventor: BERGMANN WERNER
IPC: D21H19/08
Filed: 1993-03-15
Abstract: Paper coated on one side has a top coat applied by the direct method (casting), using a compsn. contg. a film-forming synthetic resin binder (I), (wt.)% mineral pigment (II) and a natural binder (III) in an amt. of 20-60 wt.% w.r.t. the total binder content. This is applied to a satinised overcoat with one or 2 layers contg. (I) and/or (III) and (II). - The top coat contains 32-45% (III). The satinised overcoat has a Bekk smoothness of 500-3000 s. Before applying the top coat, the satinised paper has an air permeability of max. 9000 s. The amts. of coating are 7-22 g/m2 overcoat and 3-8 g/m2 top coat. The top coat has a 75 deg. Lehmann gloss of 88-98%. The top coat pref. contains 2-10% wet strength agent w.r.t. solids.
Patent FI-931733-A0 (FI)
Inventor: BLETTON OLIVIER
IPC: C22C38/42
Filed: 1993-04-16
Abstract: A weldable austenitic stainless steel with high machinability and improved cold workability, characterised in that its weight composition is the following: C lower than 0.1 %, Si lower than 2 %, Mn lower than 2 %, S lower than 0.03 %, Ni between 8 and 10 %, Cr between 15 and 25 %, P lower than or equal to 0.04 %, Mo lower than 0.5 %, Cu between 1 and 5 %, N between 0.02 and 0.07 %, Ca higher than 30x10<-4> %, O higher than 70x10<-4> %, Al lower than 50x10<-4> %, the Ca/O ratio being between 0.3 and 0.6.
Patent FI-932443-A0 (FI)
Inventor: MARZOLA ROBERTO
IPC: C08K5/04
Filed: 1993-05-28
Abstract: Disclosed are functionalized polyolefins prepared by mixing a polyolefin with a concentrate and extruding the resulting blend, wherein said concentrate is in the form of olefin polymer particles coated with a mixture of additives comprising:   A) from 0.05 to 30% by weight, based on the total weight of the concentrate, of one or more nonpolymerizable polar vinyl monomers; B) from 0.05 to 30% in moles, with respect to (A), of a free radical generating initiator which is not active at temperatures lower than or equal to 70 DEG C, and optionally, C) from 0.1 to 5% by weight, based on the total weight of the concentrate, of a coating substance.
Patent FI-955604-A0 (FI)
Inventor: SALITURO FRANCESCO GERALD
IPC: A61P9/10
Filed: 1995-11-21
Abstract: A compound of formula (I), wherein Z is hydrogen, -CH3, or -C2H5; X and Y are represented by -OH, a physiologically acceptable ester, or a physiologically acceptable amide; R is represented by from 1 to 3 substituents independently chosen from the group: hydrogen, C1-4 alkyl, C1-4 alkoxy, halogen, -CF3, or -OCF3; R1 is represented by from 1 to 3 substituents independently chosen from the group: hydrogen, amino, C1-4 alkyl, C1-4 alkoxy, halogen, -CF3, or -OCF3; and pharmaceutically acceptable addition salts thereof. These 3-indolyl-3-yl-propenoic acid derivatives are useful as NMDA antagonist.
Patent AP-9701084-A0 (AP)
Title: Method and apparatus for coordination of motion determination over multiple frames.
Inventor: MARTENS HARALD AAGAARD
IPC: H04N7/26
Filed: 1996-03-22
Abstract: The present invention concerns improved motion estimation in signal records. A method for estimating motion between one reference image and each frame in a sequence of frames, each frame consisting of a plurality of samples of an input signal comprises the steps of: (1)for each frame, estimating a motion field from the reference image to the frame, (2)for each frame, transforming the estimated motion field into a motion matrix, where each row corresponds to one frame, and each row contains each component of motion vector for each element fo the reference image, (3)performing a principal component analysis on the motion matrix, thereby obtaining a motion score matrix consisting of a plurality of row called motion loading vectors, such that each motion score vector corresponds to one element for each frame, such that each element of each motion loading vector corresponds to one element of the reference image, such that one column of said motion score matrix and one motion loading vector together constitute a factor, and such that the nmber of factors if lower than or equal to the number of said frames, (4)for each frame, multiplying the motion scores corresponding to the frame by the motion loading vectors, thereby producing a motion hypothesis for each frame, (5)for each frame, estimating a motion field from the reference image to said frame, using the motion hypothesis as side information, outputting the motion fields estimated in step (5)representing the motion between said reference image and each frame in the sequence of frames.
Patent IL-65778-A0 (IL)
Title: Suspension-type poultry drinking fountain
IPC: A01K39/022
Filed: 1982-05-14
Abstract: A suspended-type poultry drinking fountain comprises a hanger assembly including a stem adapted to be supported in a vertical position by suspension from its upper end, and a bowl supported by the hanger assembly and containing a water trough for receiving water to be made available for drinking by the poultry, The hanger assembly includes a horizontal, annular, resilient gasket circumscribing the stem, and a valve housing having a water inlet, a water outlet, and a hollow conduit member therebetween and disposed to overly the annular gasket. The fountain further includes a spring mounting the valve housing to the stem such that the weight of the water in the water trough compresses the spring to draw the hollow conduit member towards the annular gasket and thereby to automatically maintain a predetermined level of water in the water trough.
Patent IL-81374-A0 (IL)
Title: Magnesia partially-stabilized zirconia
IPC: C04B35/48
Filed: 1987-01-23
Abstract: A partially stabilised zirconia body consists of crystalline zirconia contg. 0.05-0.5 wt.% of silica and 2-5-4 wt.% magnesia. It has a structure of cubic zirconia with discrete ppts. of tetragonal and monoclinic zirconia those ppts. having an ellipsoidal shape with a long dimension of 0.1-0.4 micron. The body is characterised by specified values of rupture modulus after thermal shock and coefft of thermal expansion according to whether the monoclinic phase is present in the range 10-20 vol.% or 20-60 vol.%. The green body is sintered at 1525-1800 deg.C, cooled at controlled rate to 1300-1450 deg.C; cooled at a controlled rate to 1000-1200 deg.C and optionally aged; cooled to room temp., optionally reheated to 1000-1200 deg.C and aged. Total ageing time is 10-150 hours.
Patent IL-84570-A0 (IL)
Title: Diphosphonic acid derivatives,processes for the preparation thereof and pharmaceutical compositions containing them
IPC: A61P3/00
Filed: 1987-11-23
Abstract: Diphosphonic acids of the formula I 
<IMAGE>
 in which
 Het denotes a hydrogenated or partially hydrogenated heterocyclic ring having one or two nitrogen atoms which, independently of one another, can optionally be substituted by lower alkyl, benzyl or cyclohexylmethyl,
 B denotes a nitrogen atom or a C-H group, where the C-atom substituted by G can also form a double bond with B,
 R1 and R2 each denote hydrogen, lower alkyl or together denote an alkylene chain having 3 - 5 carbon atoms, where these can thus contain a Het-fused ring with up to 3 double bonds, 
<IMAGE>
 in which R3 denotes hydrogen or lower alkyl,
 alk denotes a valency line or a straight-chain or branched alkylene chain having 1 - 6 carbon atoms which must not start from a hetero atom,
 X denotes hydrogen, hydroxyl or an amino group,
 G denotes hydrogen or the radical Ys and
 m, r and s can each be 0 or 1, where m + r + s must always be 1,
 with the proviso that if alk denotes a valency line, Het must not represent a pyrrolidine ring substituted in the 2-position by Y,
 and their pharmacologically acceptable salts are used for the treatment of disorders of calcium metabolism.
Patent IL-89132-A0 (IL)
Title: Fried pie and process of making same
IPC: A21D13/00
Filed: 1989-01-31
Abstract: A process for preparing a partially pre-cooked pie in the nature of a microwavable, pre-fried, batter-coated, dough-enrobed foodstuff is disclosed as is the foodstuff thereby produced. In the process, a foodstuff such as chicken or Standard Pizza Filling, is enrobed with dough and then coated with an aqueous batter slurry formed by mixing an effective amount of water with a farinaceous based batter mix comprising a farinaceous material which may be starch, flour, or mixtures thereof. The batter-coated dough-enrobed foodstuff is then partially cooked in hot fat or cooking oil to pre-fry the same. The fried product is characterized by an acceptable level of crispness after freezing, prolonged freezer storage, and finally microwave cooking.
Patent IL-93421-A0 (IL)
Title: Antitumor antibiotics(ll-e33288 complex)
IPC: A61P35/00
Filed: 1990-02-16
Abstract: Antibacterial and antitumor agents designated LL-E33288 complex and their production by new strains of Micromonospora, Micromonospora echinospora ssp. calichensis, NRRL-15839 and NRRL-15975, are disclosed.
Patent SE-9003587-A0 (SE)
Title: Sätt att vid borrning/fräsning av hål i ett arbetsstycke kalibrera borr/fräsmaskinen för avsett matningsdjup
Inventor: MICAEL SCHMITZ
IPC: H05K3/00
Filed: 1990-11-09
Abstract: Uppfinningen avser ett sAtt att vid borrning/frAsning av hal i ett pA ett underlag vilande arbetsstycke Astadkomma kalibrering av den for haltagningen anvAnda borr/frAsmaskinen (1) for avsett matningsdjup och att samtidigt majliggOra detektering av verktygsbrott. UtmArkande for sAttet enligt uppfinningen ar att en elektriskt ledande del av ar- betsstycket eller av underlagets kontaktyta med arbetsstycket anordnas som del i en Oppen elektrisk krets (6) med en stromkAlla (7) och en elektrisk signalgivare (8). Borr/frasverktyget bringas under .vpAgAende Wilagningsoperation att inga som en del i den elektriska kretsen (6) for slutning av densamma under samtidig avgivning av en elektrisk styrsignal frAn signalgivaren (8) till en styrenhet for borr/frAsmaskinen (1). Styrsignalen anvAndes i styrenheten som referenspunkt f6r installning av borr/frAsverktygets matningsdjup och/eller for de- tektering av intrAffat verktygsbrott eller felaktigt genomford hAltagning. Fig 1
Patent AU-PO649897-A0 (AU)
Title: Method and arrangement for forming construction panels and structures
IPC: B28B7/00
Filed: 1997-04-28
Abstract: Method and arrangement for casting structures using form-work is disclosed applicable but no limited to on-site casting concrete construction panels for subsequent erection. Set back from form-work location are set-back buttresses (11) fixed to the work site surface. The set-back buttresses (11) support sliding risers (25-29) which can be secured in place relative to the set-back buttresses (11) and released and moved to and from the form-work location. The sliding risers (25-29) support form-work at the form-work location. A plurality of sliding risers (25-29) can be supported by the set-back buttresses (11) one above the other. In this way side-forms can be supported for structures of complex vertical profiles; for example, convex or concave walls, steps and stacks of construction panels may be moulded. Also disclosed are reusable side-forms which are supported by the sliding risers (25-29) and can be used as form work for construction panels. The side-forms can be butted together end to end and also end to face thereby continuous rectangular moulds can be made.
Patent FI-20012134-A0 (FI)
Inventor: JONNINEN MARKKU
IPC: F16H61/4165
Filed: 2001-11-05
Abstract: The invention relates to a method and apparatus for returning the oil drained from a working pressure space (10a) of a hydraulic motor (1) into a motor casing (12) to an oil line (2), which is connected,to the motor (1) and which is in communication via a divider (16) with intra-motor flow channels (13) which are in communication with the working pressure spaces (10a). The oil seeping into the casing (12) is conveyed by means of pressure variations internal of the hydraulic motor (1), pulsating consistently with rotating motion, into the oil line (2) presently at a lower pressure and connected to the motor (1) by way of said divider (16). Therefor, the casing space (12) is connected by a return conduit (6, 7) through a one-way valve (8, 14) to at least one flow channel (14), which lies between the divider (16) of the motor (1) and the working pressure space (10a) of the motor. <IMAGE>
Patent FI-20065056-A0 (FI)
Inventor: ILMONIEMI ERKKI
IPC: D21F/
Filed: 2006-01-27
Abstract: Method and equipment for the forming of a paper or board web. The headbox (17) is sealed in relation to the wires (11, 12) so that the pulp suspension is transferred from the headbox (17) to the forming zone as a closed jet without free boundary surfaces. The forming zone comprises the first dewatering element (23), which is located inside the first wire loop (11), and the second dewatering element (24), which is located inside the second wire loop (12), so that between them, they provide the borders for the initial dewatering zone which narrows in the flow direction. In the initial dewatering zone, water is removed from the pulp suspension through the openings (26, 27) in the cover of the dewatering elements (23, 24). After the initial dewatering zone, the wires (11, 12) are led over the curved cover of the forming shoe (29) while at the same time pressure pulses are exerted on the pulp suspension located between the wires (11, 12) by means of dewatering blades (28) located on the cover of the forming shoe (29). The length (L 0 ) of the initial dewatering zone bordered by the dewatering elements (23, 24) is at the most 50 % of the length (L 1 ) of the forming shoe (29) following it.
Patent IL-100555-A0 (IL)
Title: N-substituted quinoline derivatives,their preparation process,the new intermediates obtained,their use as medicaments and the pharmaceutical compositions containing them
IPC: C07D215/48
Filed: 1991-12-30
Abstract: Product of formula (ID): <IMAGE>  in which: <IMAGE>     D1, D2, D3 and D4 nitrogen, methine or methylene,   R1B hydrogen, alkyl, alkenyl, alkynyl, acyl, cyano or carboxy,   RB, R2B and R3B:   a) hydrogen, halogen, hydroxyl, mercapto, cyano, nitro, sulpho, formyl, benzoyl, acyl, carboxy or cycloalkyl,   b) alkyl, alkenyl, alkynyl, alkyloxy, alkylthio,   c) aryl, arylalkyl, arylalkenyl, aryloxy or arylthio   d) <IMAGE>     R5B alkylene,   YB represents -Y1B-B-Y2B:   Y1B represents aryl   B represents:   either a single bond between Y1B and Y2B,   or: -CO-, -NH-CO-, -CO-NH-, -O-(CH2)n- or -S-(CH2)n- (n = 0 to 4),   Y2B represents: either, if B represents a single bond, hydrogen, halogen, hydroxyl, cyano, nitro, trifluoromethyl, carboxy, tetrazole or isoxazole,   or, irrespective of the nature of B, Y1B.   These products justify their use as pharmaceuticals.
Patent IL-102460-A0 (IL)
Title: Method for enhancing the immunotherapeutic activity of lymphocytes and agents and kits containing lymphocytes of enhanced activity
IPC: A61K35/14
Filed: 1992-07-10
Abstract: The present invention is directed to a method of increasing the in vivo immune response of lymphocytes by stimulating the lymphocytes in vitro in the presence of an anti-CD3 monoclonal antibody for less than about 24 hours to form stimulated lymphocytes; infusing the stimulated lymphocytes into a tumor-bearing mammal; and administering IL-2 to the mammal. As a result of this method, the anti-CD3 stimulated lymphocytes display enhanced immunotherapeutic, e.g., cytotoxicity or lymphokine production, in vivo as represented by a decrease in the number of tumors by at least about 20%.
Patent IL-106463-A0 (IL)
Title: Arginine derivatives,their preparation and pharmaceutical compositions containing them
IPC: A61P9/02
Filed: 1993-07-23
Abstract: (S)-N5-[Imino(methylamino)methyl]ornithine hydrochloride, pharmaceutical compositions containing it, its us in medicine and its preparation is described.
Patent IL-113436-A0 (IL)
Title: Neurotransmitter release enhancers
IPC: C07D249/04
Filed: 1995-04-20
Abstract: PCT No. PCT/IB95/00189 Sec. 371 Date Feb. 19, 1997 Sec. 102(e) Date Feb. 19, 1997 PCT Filed Mar. 20, 1995 PCT Pub. No. WO95/29909 PCT Pub. Date Nov. 9, 1995This invention relates to compounds of formula (IA), (IB), (IC) or (ID), wherein m, X, Z, R2, R3, R4, R5, R6, R14 and the dotted lines are as defined below, their pharmaceutically acceptable salts, pharmaceutical compositions containing them and methods of using them to treat Alzheimer's disease, age-associated memory impairment, Parkinson's disease and other central nervous system disorders. The claimed compounds have the ability to enhance the release of neurotransmitters such as acetylcholine, dopamine and serotonin.    <IMAGE>  (IA)
Patent IL-114028-A0 (IL)
Title: A method for obtaining pure enantiomers of 6-(4-amino-phenyl)-5- methyl-pyridazin 3(2H) one
IPC: C07D237/14
Filed: 1991-12-30
Abstract: PCT No. PCT/FI92/00003 Sec. 371 Date Jun. 30, 1993 Sec. 102(e) Date Jun. 30, 1993 PCT Filed Jan. 3, 1992 PCT Pub. No. WO92/12135 PCT Pub. Date Jul. 23, 1992.Optically substantially pure (-) enantiomer of [[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl]hydrazono)propanedinitrile or pharmaceutically acceptable salt thereof, intermediates and a process for the preparation are described. The product is useful as a cardiotonic agent, antihypertensive and vasodilator for the treatment of congestive heart failure.
Patent IL-114456-A0 (IL)
Title: Process for the purification of magnesium hydroxide
IPC: A61K33/08
Filed: 1995-07-05
Abstract: A process for preparing magnesium hydroxide having high purity which comprises dispersing the raw product in water, under stirring, then adjusting the pH to a value comprised between 10,0 and 14,0; adding a chelating agent and separing the resulting phases.
Patent IL-114629-A0 (IL)
Title: Intermediates for the preparation of cephalosporins
IPC: C07D501/46
Filed: 1995-07-17
Abstract: The invention relates to the products of formula: <IMAGE>  in which:     R1 =, in particular, <IMAGE> or <IMAGE>   Rb and Rc = H or acyl A and A' =, in particular H, alkali metal equivalent, aminated organic base, readily cleavable ester group, or CO2A represents CO2<(-)> to a process for their preparation, to their use as medicaments, to compositions containing them and to the new intermediates obtained.
Patent IL-122120-A0 (IL)
Title: Recombinant MVA virus and the use thereof
IPC: C12N15/49
Filed: 1996-07-03
Abstract: Recombinant MVA viruses containing and capable of expressing foreign genes which is inserted at the site of a naturally occuring deletion within the MVA genome, and the use of such recombinant MVA viruses for the production of polypeptides, e.g. antigenes or therapeutic agents, and for the production of recombinant viruses for vaccines, or viral vectors for gene therapy.
Patent IL-123585-A0 (IL)
Title: Novel N-aminoalkylfluorene-carboxamides a new class of dopamine receptor subtype specific ligands
IPC: C07D211/18
Filed: 1996-09-12
Abstract: Disclosed are compounds of formula (I) or the pharmaceutically acceptable salts thereof wherein: G represents a group of the formula (a), (b) or (c) where Ra and Rb represent hydrogen, or organic or inorganic substituents; A is an optionally substituted alkylene; R1, R2, R3, R4 represent organic or inorganic substituents; R5 is hydrogen or lower alkyl; R6 and R7 independently represent hydrogen, lower alkyl; or together form a ring of 5-8 members; Z is nitrogen or carbon; and W is optionally substituted aryl or heteroaryl.
Patent IL-125841-A0 (IL)
Title: Process for preparing nitrobiphenyls
IPC: C07C253/30
Filed: 1997-03-06
Abstract: The invention concerns a process for preparing nitrobiphenylene of formula (I) wherein m stands for 1 or 2, R means halogen, R' or OR', R' being a C-organic group which can carry groups which are inert in the reaction conditions, n stands for 0, 1, 2 or 3 and, if n is 2 or 3, the R groups can also be different. According to the invention, a chloronitrobenzene of formula (II) is reacted in the presence of a palladium catalyst and a base in a solvent with a phenyl boric acid (IIIa), one of its alkyl esters of formula (IIIb), R<1> meaning C1-C6 alkyl, or one of its anhydrides. The compounds (I) are suitable as initial products for biphenylamines which are in turn intermediate products for fungicidal plant-growth substances.
Patent IL-129337-A0 (IL)
Title: Bicyclic aryl carboxamides and their therapeutic use
IPC: C07D401/12
Filed: 1997-11-17
Abstract: Compounds of the formula (i)  have therapeutic utility via inhibition of TNF or phosphodiesterase.